These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26695166)

  • 41. Nonmedical Stimulant Use in College Students: Association With Attention-Deficit/Hyperactivity Disorder and Other Disorders.
    Wilens T; Zulauf C; Martelon M; Morrison NR; Simon A; Carrellas NW; Yule A; Anselmo R
    J Clin Psychiatry; 2016 Jul; 77(7):940-7. PubMed ID: 27464314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences.
    Bogle KE; Smith BH
    Curr Drug Abuse Rev; 2009 May; 2(2):157-76. PubMed ID: 19630746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Collegiate misuse of prescription stimulants: examining differences in self-worth.
    Giordano AL; Prosek EA; Reader EA; Bevly CM; Turner KD; LeBlanc YN; Vera RA; Molina CE; Garber SA
    Subst Use Misuse; 2015 Feb; 50(3):358-65. PubMed ID: 25474729
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attention-deficit/hyperactivity disorder and substance abuse.
    Harstad E; Levy S;
    Pediatrics; 2014 Jul; 134(1):e293-301. PubMed ID: 24982106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prescription Stimulant Misuse and Diversion Events Among College Students: A Qualitative Study.
    Garcia C; Valencia B; Diaz Roldan K; Garcia J; Amador Ayala J; Looby A; McMullen J; Bavarian N
    J Prev (2022); 2022 Feb; 43(1):49-66. PubMed ID: 34729661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
    Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
    Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methylphenidate transdermal system in adults with past stimulant misuse: an open-label trial.
    McRae-Clark AL; Brady KT; Hartwell KJ; White K; Carter RE
    J Atten Disord; 2011 Oct; 15(7):539-44. PubMed ID: 20538968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate.
    Busardò FP; Kyriakou C; Cipolloni L; Zaami S; Frati P
    Curr Neuropharmacol; 2016; 14(1):17-27. PubMed ID: 26813119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Knowledge, Attitudes, and Practice Patterns of Health Professionals Toward Medical and Non-medical Stimulant Use by Young Adults.
    Loskutova NY; Waterman J; Callen E; Staton EW; Bullard E; Shields J
    J Am Board Fam Med; 2020; 33(1):59-70. PubMed ID: 31907247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and efficacy considerations due to misuse of extended-release formulations of stimulant medications.
    Jain R; Stark JG
    Postgrad Med; 2016 Sep; 128(7):672-81. PubMed ID: 27467139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood.
    Mannuzza S; Klein RG; Truong NL; Moulton JL; Roizen ER; Howell KH; Castellanos FX
    Am J Psychiatry; 2008 May; 165(5):604-9. PubMed ID: 18381904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
    Fone KC; Nutt DJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-Term Treatment Outcome in Adult Male Prisoners With Attention-Deficit/Hyperactivity Disorder: Three-Year Naturalistic Follow-Up of a 52-Week Methylphenidate Trial.
    Ginsberg Y; Långström N; Larsson H; Lindefors N
    J Clin Psychopharmacol; 2015 Oct; 35(5):535-43. PubMed ID: 26284932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stimulant medication use in college students: comparison of appropriate users, misusers, and nonusers.
    Hartung CM; Canu WH; Cleveland CS; Lefler EK; Mignogna MJ; Fedele DA; Correia CJ; Leffingwell TR; Clapp JD
    Psychol Addict Behav; 2013 Sep; 27(3):832-40. PubMed ID: 24059834
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult].
    Durst R; Rebaudengo-Rosca P
    Harefuah; 1997 May; 132(9):618-22, 680. PubMed ID: 9225572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].
    Frölich J; Banaschewski T; Spanagel R; Döpfner M; Lehmkuhl G
    Z Kinder Jugendpsychiatr Psychother; 2012 Sep; 40(5):287-99; quiz 299-300. PubMed ID: 22869222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
    Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.